ROYAL BANK OF CANADA
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1000275
TORONTO, A6
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$486,924,048
-$9,570,822 QoQ
Shares Held
980,259
-11.8% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#37
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Dec 31, 2025CallValue
$45,336,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,518 across 427 Biotechnology names. VRTX ranks #2 (23.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in VRTX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $486,924,048 | 980,259 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $496,494,870 | 1,111,871 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $541,543,954 | 1,194,512 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $45,336,000 | 100,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $467,504,189 | 1,193,709 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $616,320,627 | 1,384,368 | Shares | Other | 2025-11-21 | |
| 2025-03-31 | $585,986,413 | 1,208,668 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $584,301,184 | 1,450,959 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $729,076,146 | 1,567,636 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $788,199,544 | 1,681,600 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $209,005 | 500 | Put | Defined | 2024-11-05 | |
| 2024-03-31 | $631,698,378 | 1,511,204 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $591,810,106 | 1,454,472 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $427,788,350 | 1,230,196 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $428,473,644 | 1,217,566 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $354,666,733 | 1,125,676 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $277,353,546 | 960,432 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $267,314,904 | 923,240 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $249,450,366 | 885,235 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $219,239,587 | 840,095 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $154,532,296 | 703,699 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $141,591,216 | 780,590 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $216,175,783 | 1,072,141 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $180,846,692 | 841,578 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $207,258,121 | 876,949 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $198,628,274 | 729,929 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $169,360,461 | 583,378 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $126,846,144 | 533,079 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||